Archives
-
Episode 19- Public service announcement: stop the steroid bomb!
Stop the steroid bomb! If you are giving 125 mg IV methylprednisolone (Solu-Medrol) to your asthma or COPD exacerbation patients, that may be too much.
-
Episode 18- Ventilator-associated tracheo-what?
Tune in as we discuss ventilator-associated tracheobronchitis and what the guidelines say we should do about this little-known entity!
-
Episode 17- The Emergency Medical Minute meets ER-Rx
In case you missed it, last week Dr. Nick Tsipis from the Emergency Medical Minute discussed a few rapid-fire ER topics with our host, Adis Keric. Check out the full episode here or on the Emergency Medical Minute podcast!
-
Episode 16- “HALT” the use of TXA in GI bleeds?
This week, we review the "HALT-IT" trial. Will you routinely give your patients TXA (tranexamic acid) in the setting of GI bleeds after reading this study?
-
Episode 15- The misleading “sulfa” allergy
Today, we discuss what it means to have a "sulfa" allergy. Are things such as furosemide and tamsulosin really contraindicated in these patients?
-
Episode 14- SARS-CoV-2 antibody test
What does a negative or positive antibody test mean? Should it change our behavior? Do we have to view the results in the setting of where we are located? Tune in this week!
-
Episode 13- “Clot Busters:” Part 2: Cardiac arrest
In Part 2 of 2 of our "Mini Grand Rounds" series, we discuss the use of thrombolytics in the setting of cardiac arrest and wrap it up with our final recommendations.
-
Episode 12- “Clot Busters:” Part 1: Submassive and massive pulmonary embolism
In Part 1 of 2 of our "Mini Grand Rounds" series, we discuss the use of thrombolytics in the setting of submassive and massive pulmonary embolism.
-
Episode 11- Anaphylaxis: A pharmacologic management update
What is the most important agent for anaphylaxis? What other treatments are only considered as adjuncts? How should I give these agents? Find out this week as we review updated anaphylaxis treatment guidelines published in April 2020!
-
Episode 10- Alteplase door-to-needle times and long-term outcomes
Join us for a quick review on a recently-published study describing the association between alteplase door-to-needle times and long-term patient outcomes in the setting of ischemic stroke.